+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Flow Cytometry Market Report and Forecast 2024-2032

  • PDF Icon


  • 140 Pages
  • February 2024
  • Region: Global
  • Expert Market Research
  • ID: 5797933

Global Flow Cytometry Market Outlook

The global flow cytometry market size was valued at USD 5.3 billion in 2023, driven by increase prevalence of cancer and immunological diseases across the globe. The market size is anticipated to grow at a CAGR of 7.8% during the forecast period of 2024-2032 to achieve a value of USD 10.4 billion by 2032.

Flow Cytometry: Introduction

Flow cytometry is a powerful analytical technology used to analyze the physical and chemical characteristics of cells or particles in a fluid as it passes through at least one laser. Cell components are fluorescently labeled and then excited by the laser to emit light at varying wavelengths. The intensity of the light emitted, measured and analyzed by detectors, provides detailed information about cell size, granularity, and the abundance of biomolecules, facilitating advanced research and clinical diagnostics.

Key Trends in the Global Flow Cytometry Market

Continuous innovation in flow cytometry technology, including the development of high-throughput systems and advancements in cell sorting and analysis techniques, is enhancing the capabilities and applications of flow cytometry.

The use of flow cytometry in clinical diagnostics, drug discovery, and immunology research is expanding, driven by its ability to provide detailed cellular analysis and support personalized medicine approaches.

The rising incidence of diseases such as cancer and immunological disorders is driving the demand for flow cytometry in disease diagnosis and monitoring, as well as in research focused on understanding disease mechanisms and developing targeted therapies.

Flow cytometry is increasingly being integrated with other analytical techniques, such as mass spectrometry and molecular diagnostics, to enhance the comprehensiveness and accuracy of analysis.

Flow cytometry is finding new applications in fields such as agriculture, where it is used for cell counting, sorting, and biomarker detection in various crop species.

There's a growing trend towards developing customized flow cytometry solutions tailored to specific research and clinical needs, as well as automation of flow cytometry processes to improve efficiency and reproducibility.

Global Flow Cytometry Market Segmentation

Market Breakup by Product & Service

  • Instruments
  • Cell Analyzers
  • Cell Sorters
  • Reagents & Consumables
  • Software
  • Accessories
  • Services

Market Breakup by Technology

  • Bead-based
  • Cell-based

Market Breakup by Application

  • Research
  • Pharmaceutical & Biotechnology
 Drug Discovery
 Stem Cell Research
 In Vitro Toxicity Testing
 Apotosis
 Cell Sorting
 Cell Cycle Analysis
 Immunology
 Cell Viability
 Others
  • Industrial
  • Clinical
  • Cancer Diagnostics
  • Organ Transplantation
  • Autoimmune Diseases
  • Hematology
  • Others

Market Breakup by End-use

  • Commercial Organizations
  • Biotechnology Companies
  • Pharmaceutical Companies
  • CRO’s
  • Hospitals
  • Academic Institutes
  • Clinical Testing Labs

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Flow Cytometry Market Overview

North America is a leading in market due to advanced healthcare infrastructure, a high prevalence of cancer, and significant investments in research and development. The United States. is particularly prominent, with numerous ongoing clinical trials and a strong focus on innovation in Flow Cytometry technologies.

Europe has a strong market, particularly in Western European countries like Germany, the UK, and France, driven by advanced healthcare systems, substantial R&D activities, and favorable regulatory environments. Increasing focus on personalized medicine and cancer screening programs contributes to the growth of the Flow Cytometry market.

Asia-Pacific is the fastest-growing region, driven by rising cancer prevalence, improving healthcare infrastructure, and increasing investments in healthcare technologies. Countries like China and Japan are heavily investing in healthcare technology, including Flow Cytometry, and are becoming significant markets in the region.

Latin America has become an emerging market with growing awareness of cancer and its early detection. Investments in healthcare infrastructure and increasing accessibility to advanced medical technologies are driving the market growth in this region.

Middle East & Africa came out as a gradual growth in the market, influenced by improving healthcare facilities and increasing awareness about non-invasive diagnostic methods. The market growth is primarily concentrated in urban and more developed parts of the region.

Global Flow Cytometry Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Danaher Corp.
  • Becton, Dickinson, and Company (BD)
  • Sysmex Corp.
  • Agilent Technologies, Inc.
  • Apogee Flow Systems Ltd.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • Stratedigm, Inc.
  • DiaSorin SpA
  • Miltenyi Biotec
  • Sony Biotechnology, Inc.

This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Flow Cytometry Market Overview
3.1 Global Flow Cytometry Market Historical Value (2017-2023)
3.2 Global Flow Cytometry Market Forecast Value (2024-2032)
4 Global Flow Cytometry Market Landscape
4.1 Global Flow Cytometry Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Flow Cytometry Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Technology
4.2.3 Analysis by Application
4.2.4 Analysis by End-use
5 Global Flow Cytometry Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Flow Cytometry Market Segmentation
6.1 Global Flow Cytometry Market by Product & Services
6.1.1 Market Overview
6.1.2 Instruments Cell Analysers Cell Sorters
6.1.3 Reagents & Consumables
6.1.4 Software
6.1.5 Accessories
6.1.6 Services
6.2 Global Flow Cytometry Market by Technology
6.2.1 Market Overview
6.2.2 Bead-based
6.2.3 Cell-based
6.3 Global Flow Cytometry Market by Application
6.3.1 Market Overview
6.3.2 Research Pharmaceutical & Biotechnology Drug Discovery Stem Cell Research In Vitro Toxicity Testing Apotosis Cell Sorting Cell Cycle Analysis Immunology Cell Viability Others
6.3.3 Industrial
6.3.4 Clinical Cancer Diagnostics Organ Transplantation Autoimmune Diseases Hematology Others
6.4 Global Flow Cytometry Market by End-use
6.4.1 Market Overview
6.4.2 Commercial Organizations
6.4.3 Biotechnology Companies
6.4.4 Pharmaceutical Companies
6.4.5 CRO’s
6.4.6 Hospitals
6.4.7 Academic Institutes
6.4.8 Clinical Testing Labs
6.5 Global Flow Cytometry Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Flow Cytometry Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Flow Cytometry Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Flow Cytometry Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Others
10 Latin America Flow Cytometry Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Flow Cytometry Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by Year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.2 US FDA
16.3 EU EMA
16.6 Others
17 Supplier Landscape
17.1 Danaher Corp.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Becton, Dickinson, and Company (BD)
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Beckman Coulter, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Sysmex Corp.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Agilent Technologies, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Apogee Flow Systems Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Bio-Rad Laboratories, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Thermo Fisher Scientific, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Stratedigm, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 DiaSorin SpA
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Miltenyi Biotec
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Sony Biotechnology, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Merck KGaA
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Luminex Corporation
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Nanocellect Biomedical
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions Certifications
18 Global Flow Cytometry Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • Danaher Corp.
  • Becton
  • Dickinson
  • and Company (BD)
  • Beckman Coulter Inc.
  • Sysmex Corp.
  • Agilent Technologies Inc.
  • Apogee Flow Systems Ltd.
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Stratedigm Inc.
  • DiaSorin SpA
  • Miltenyi Biotec
  • Sony Biotechnology Inc.
  • Merck KGaA
  • Luminex Corporation
  • Nanocellect Biomedical



Table Information